PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.22%
Revenue growth above 1.5x FSLR's 25.75%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
64.11%
Gross profit growth above 1.5x FSLR's 26.70%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
165.49%
EBIT growth above 1.5x FSLR's 21.41%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
49.95%
Operating income growth above 1.5x FSLR's 21.41%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
245.39%
Net income growth above 1.5x FSLR's 9.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
325.00%
EPS growth above 1.5x FSLR's 7.46%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
316.67%
Diluted EPS growth above 1.5x FSLR's 6.03%. David Dodd would see if there's a robust moat protecting these shareholder gains.
8.51%
Share count expansion well above FSLR's 2.49%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
17.51%
Diluted share count expanding well above FSLR's 3.70%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
105.32%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
53.59%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
251.78%
10Y revenue/share CAGR under 50% of FSLR's 7925.22%. Michael Burry would suspect a lasting competitive disadvantage.
251.78%
5Y revenue/share CAGR under 50% of FSLR's 2548.31%. Michael Burry would suspect a significant competitive gap or product weakness.
283.50%
3Y revenue/share CAGR at 50-75% of FSLR's 490.48%. Martin Whitman would question if the firm lags behind competitor innovations.
-97.12%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-97.12%
Negative 5Y OCF/share CAGR while FSLR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-56.68%
Negative 3Y OCF/share CAGR while FSLR stands at 243.77%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
143.82%
Below 50% of FSLR's 2322.09%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
143.82%
Below 50% of FSLR's 42047.53%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
87.49%
Below 50% of FSLR's 252.51%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
Below 50% of FSLR's 311.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
96.93%
AR growth well above FSLR's 90.09%. Michael Burry fears inflated revenue or higher default risk in the near future.
-23.39%
Inventory is declining while FSLR stands at 23.60%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
16.24%
Asset growth at 50-75% of FSLR's 27.17%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
7.98%
Under 50% of FSLR's 30.70%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
43.10%
Debt growth far above FSLR's 2.37%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-13.03%
Our R&D shrinks while FSLR invests at 58.96%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
0.79%
SG&A declining or stable vs. FSLR's 47.88%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.